HA14-1, a small molecule Bcl-2 antagonist, induces apoptosis and modulates action of selected anticancer drugs in follicular lymphoma B cells
Authors:
- Joanna SkommerJSJoanna Skommer
- Donald WlodkowicDWDonald Wlodkowic
- Mikko MättöMMMikko Mättö
- Mine ErayMEMine Eray
- Jukka PelkonenJPJukka Pelkonen
- 1 March 2006
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 30 (3) , 322-331
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis Is Inhibited by Bcl-2 but Restored by the Small Molecule Bcl-2 Inhibitor, HA 14-1, in Human Colon Cancer CellsClinical Cancer Research, 2004
- Evaluation of Combination ChemotherapyClinical Cancer Research, 2004
- Therapeutic potential of antisense Bcl‐2 as a chemosensitizer for cancer therapyCancer, 2004
- A Bcr/Abl-independent, Lyn-dependent Form of Imatinib Mesylate (STI-571) Resistance Is Associated with Altered Expression of Bcl-2Journal of Biological Chemistry, 2004
- The Pathophysiology of Mitochondrial Cell DeathScience, 2004
- Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and CardiotoxicityPharmacological Reviews, 2004
- G3139, a Bcl-2 antisense oligodeoxynucleotide, induces clinical responses in VAD refractory myelomaLeukemia, 2004
- Potentiation of dexamethasone-, paclitaxel-, and Ad-p53–induced apoptosis by Bcl-2 antisense oligodeoxynucleotides in drug-resistant multiple myeloma cellsBlood, 2003
- Chemosensitization of myeloma plasma cells by an antisense-mediated downregulation of Bcl-2 proteinLeukemia, 2003
- Cellular Pharmacology of P-ethoxy Antisense Oligonucleotides Targeted to Bcl-2 in a Follicular Lymphoma Cell LineLeukemia & Lymphoma, 2003